Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • Leadership
    • Team
    • Publications
    • Careers
  • Diseases/Disorders
    • One Brain
    • ALS
    • Alzheimer’s
    • Autism
    • Brain Cancer
    • Brain Injury
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • Other
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
  • Ways To Give
    • Your Impact
    • How You Can Help
    • Events

Funded Grants

Back to results

Physical fingerprints of single extracellular vesicles for liquid biopsy in brain cancer

Project Overview

Need for project: Glioblastoma (GBM) is an incurable brain cancer that changes rapidly confounding standard diagnostic and therapeutic methods. These changes in molecular composition can be captured by bits of cancer cells known as extracellular vesicles (EVs) found in blood of patients (liquid biopsy), but it is very difficult to extract information from myriads of EV molecules. We propose a new technology for molecular profiling of single EVs to break the diagnostic and therapeutic gridlock in GBM.

Goal of project: We will harness EVs for liquid biopsy with a radically different technology. We bring together four disciplines (bioengineering, oncology, physics and tumour/EVs biology) to develop a new nanoplatform for molecular analysis of single EVs. This approach will yield a physical representation of molecular complexity of tumour cell populations, removing the roadblock in development of effective therapies.

Project description: Study on GBM will help us establish a broader link between physical and molecular properties of EVs. Our approach combines EV confinement in nanocavities, permitting simultaneous charge and size profiling, along with molecular profiling based on a method called Surface-Enhanced-Raman-Spectroscopy (SERS). This technology will output a physical fingerprint reflecting the bioactive cargo of a single glioma EV, including molecules responsible for malignancy and drug resistance.

Future impact: The ability to obtain a real-time glimpse into molecular hallmarks of cancer could transform the outcomes of presently incurable brain tumours such as GBM and metastatic cancers. This non-invasive liquid biopsy utilizing single EV physical properties and decoded SERS signal will enable treating each patient individually according to the unique molecular landscape of their specific cancer, moving away from the present ‘one-size-fits-all’ paradigm to more adaptive and effective protocols.

Principal Investigator

Sara Mahshid , McGill University

Partners and Donors

Canadian Cancer Society

Canadian Institutes of Health Research

Project Ongoing

Physical fingerprints of single extracellular vesicles for liquid biopsy in brain cancer

  • Program Type

    Team grants

  • Area of research

    Cancer

  • Disease Area

    Brain Cancer

  • Competition

    CCS/CIHR/BC Spark Grant: Novel Technology Applications in Cancer Prevention and Early Detection

  • Province

    Québec

  • Start Date

    2021

  • Total Grant Amount

    $150,000

  • Health Canada Contribution

    $75,000

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

+1 (514) 989-2989 info@braincanada.ca

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign up

© 2023 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co